Citra Nusantara Gemilang Tbk. vs Multi Medika Internasional Tbk. — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp153 (market cap 263.95B, 1.92M 24h volume), while Multi Medika Internasional Tbk. trades at Rp760 (market cap 3.6T, 20.81M 24h volume). The key difference: Multi Medika Internasional Tbk. is far larger — about 13.6× Citra Nusantara Gemilang Tbk.'s market cap, and Multi Medika Internasional Tbk. is more actively traded (20.81M versus 1.92M). Which is the better fit depends on your goals.
| CGAS | MMIX | |
|---|---|---|
Market Cap | 263.95B | 3.6T |
Volume | 1.92M | 20.81M |
Lot | 19.2K | 208.06K |
Turnover | 292.09M | 15.63B |
Average Price | 152.1 | 751.11 |
Value | 292.09M | 15.63B |
Indicative Equilibrium Price | 153 | 760 |
Indicative Equilibrium Volume | 1.91K | 362 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →PT Multi Medika Internasional Tbk (the Entity) was established based on the Notarial Deed of Ilmiawan Dekrit S., S.H., M.H., No. 23, dated September 28, 2020. The Entity commenced its commercial operations in 2020.
Read more on MMIX →